1. Home
  2. VYGR vs MYFW Comparison

VYGR vs MYFW Comparison

Compare VYGR & MYFW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$4.02

Market Cap

226.8M

Sector

Health Care

ML Signal

HOLD

MYFW

First Western Financial Inc.

HOLD

Current Price

$26.43

Market Cap

255.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
VYGR
MYFW
Founded
2013
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
226.8M
255.0M
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
VYGR
MYFW
Price
$4.02
$26.43
Analyst Decision
Strong Buy
Buy
Analyst Count
6
2
Target Price
$17.00
$24.25
AVG Volume (30 Days)
375.7K
31.2K
Earning Date
11-10-2025
01-22-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
391.62
EPS
N/A
1.28
Revenue
$31,316,000.00
$95,514,000.00
Revenue This Year
N/A
$15.96
Revenue Next Year
$71.78
$13.77
P/E Ratio
N/A
$20.65
Revenue Growth
N/A
19.92
52 Week Low
$2.65
$17.10
52 Week High
$5.96
$28.00

Technical Indicators

Market Signals
Indicator
VYGR
MYFW
Relative Strength Index (RSI) 46.28 62.88
Support Level $3.89 $25.82
Resistance Level $4.19 $27.15
Average True Range (ATR) 0.19 0.70
MACD 0.00 -0.05
Stochastic Oscillator 50.57 43.94

Price Performance

Historical Comparison
VYGR
MYFW

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About MYFW First Western Financial Inc.

First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.

Share on Social Networks: